Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 9/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 9/20 | 0.43 |
| ▸ | BCL2 | P10415 | 5/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 3/20 | 0.40 |
| ▸ | TMPRSS6 | Q8IU80 | 3/20 | 0.40 |
| ▸ | ITGAV | P06756 | 3/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7411794 | 0.96 | POLB (0.48) | POLBITGB3ITGA2BBCL2MCL1 | |
| Trifluoroacetic Acid SCHEMBL7414956 | 0.91 | BCL2 (0.49) | ITGB3ITGA2BBCL2MCL1 | |
| SCHEMBL7420503 | 0.90 | BCL2 (0.38) | POLBITGB3ITGA2BBCL2MCL1 | |
| Trifluoroacetic Acid SCHEMBL7416081 | 0.88 | POLB (0.47) | POLBITGB3ITGA2BF2TMPRSS6 | |
| Trifluoroacetic Acid SCHEMBL7414945 | 0.87 | ITGB3 (0.52) | ITGB3ITGA2BF2TMPRSS6MMP2 | |
| Trifluoroacetic Acid SCHEMBL7418348 | 0.87 | TYMS (0.45) | POLBITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7412090 | 0.87 | ITGB3 (0.47) | ITGB3ITGA2BF2TMPRSS6ITGAV | |
| SCHEMBL7695355 | 0.86 | BCL2 (0.49) | ITGB3ITGA2BBCL2MCL1 | |
| Trifluoroacetic Acid SCHEMBL7416567 | 0.86 | ITGB3 (0.55) | ITGB3ITGA2BF2TMPRSS6ITGAV | |
| Trifluoroacetic Acid SCHEMBL7415231 | 0.85 | ITGB3 (0.52) | ITGB3ITGA2BF2TMPRSS6ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6344484-B1 | TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-02-05 | — | — | US | disclosed |
| EP-1159262-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000047552-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | disclosed |